eExicure XCUR stock price is down -15% in the last 5 days & volume is up 166%, but can it bounce? 🏀
In this in depth report, I look at 5 KPIs: Technical Analysis, Volume, News Cycle, Fundamentals & awareness campaigns.
Before we get started, I like being methodical and easy to understand so I have developed a ranking system for my stocks. I call it, Alexander Goldman’s “HOT Stock Ranking!”
The official heat level for XCUR is, a 🔥2 out of 4
Before I get ahead of myself and just jump right into this exciting breakout stock, I wanted to introduce myself.
Hello 🙋♂️ My name is Alexander Goldman. I have been trading small cap stocks, breakout stocks and trending stocks for 20 years now. I established the coveted HOT Stock Reporting system.
To find out more about my story, CLICK HERE
[thrive_leads id=’28419′]
Exicure Company Information
Company Name: Exicure Inc.
Ticker: XCUR
Exchange: NASDAQ
Website: https://www.exicuretx.com/
Exicure Company Summary:
Exicure,, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.
XCUR stock price is due to News?
May 10th
Announced that it has agreed to sell an aggregate of 26,021,111 shares of its common stock at a purchase price of $0.1937 per share to certain accredited investors in a private placement in public equity (“PIPE”) financing. The purchase price of $0.1937 per share of common stock represents an approximately 45% premium to the 10-day volume weighted-average share price from May 9, 2022. Exicure anticipates that the gross proceeds from the PIPE will be approximately $5 million, before deducting transaction-related expenses payable by the Company. The Company intends to use the net proceeds from this offering to support the development of the advancement of its preclinical program, including the development of its SCN9A product candidate, as well as other working capital and general corporate purposes.
Trending Stock XCUR 5 Day Chart
XCUR Stock Price HOT Stock Grade:
EBML is, a 🔥🔥2 out of 4 . Here are my takeaways on it and why it is just a 3 out of 4.
XCUR Trading Volume
The volume, the normal trading volume is established by the previous 30 days of trading and this stock is trading at an increase of 166% over the average. Normally, this indicates a higher demand in the stock or a sell off (selling pressure).
Trading 101: volume is measured in the number of shares traded. Traders look to volume to determine liquidity and combine changes in volume with technical indicators to make trading decisions. So, let’s take a look at the technical indicators.
XCUR Technicals
The technical analysis “chart reading”, this stock is down 15% on the 5 day chart and the overall trend for the long term chart, the 1 month, is down 35%. What can I say, the stock is a real loser!
Trading 101: Technical indicators are technical tools that help in analyzing the movement in the stock prices whether the ongoing trend is going to continue or reverse. It helps the traders to make entry and exit decisions of a particular stock. Technical indicators can be leading or lagging indicators.
XCUR News Cycle
The news, there is significant news, “nnounced that it has agreed to sell an aggregate of 26,021,111 shares of its common stock at a purchase price of $0.1937 per share to certain accredited investors in a private placement in public equity (“PIPE”) financing.”
XCUR Fundamentals
The fundamentals, how a company is doing financially can be a serious KPI and there is no exciting financial filings associated with this stock. Down 102% now that is horrible!
Trading 101: Fundamental trading is a method where a trader focuses on company-specific events to determine which stock to buy and when to buy it. Trading on fundamentals is more closely associated with a buy-and-hold strategy rather than short-term trading.
XCUR Awareness
Marketing efforts “Awareness Campaigns” Just like advertising a product is important, advertising a publicly traded company during a news cycle is critical for the stock price of a company.
I have not found marketing efforts around the investor awareness of this company. So, I have awarded this stock a 2 out of 4. Do you agree? Write me a line at [email protected]
Again, two heads are better than one, let’s work together to have the best trading year of our lives!
To receive my 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.
To find out more about my story, CLICK HERE
👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥 HOT stocks and we can compare notes!👇
[thrive_leads id=’28419′]
